Type 1 Excludes Crosswalk

The following 3,420 ICD-10-CM codes contain 'Type 1 Excludes' annotation references within one-to-many other ICD-10-CM codes.

Displaying codes 701-800 of 3,420:

  • C92.1: D47.1
    2019 ICD-10-CM Diagnosis Code D47.1

    Chronic myeloproliferative disease

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Chronic neutrophilic leukemia
    • Myeloproliferative disease, unspecified
    Type 1 Excludes
    • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
    • chronic myeloid leukemia BCR/ABL-positive (C92.1-)
    • myelofibrosis NOS (D75.81)
    • myelophthisic anemia (D61.82)
    • myelophthisis (D61.82)
    • secondary myelofibrosis NOS (D75.81)
  • C92.10: C92.0
    2019 ICD-10-CM Diagnosis Code C92.0

    Acute myeloblastic leukemia

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Applicable To
    • Acute myeloblastic leukemia, minimal differentiation
    • Acute myeloblastic leukemia (with maturation)
    • Acute myeloblastic leukemia 1/ETO
    • Acute myeloblastic leukemia M0
    • Acute myeloblastic leukemia M1
    • Acute myeloblastic leukemia M2
    • Acute myeloblastic leukemia with t(8;21)
    • Acute myeloblastic leukemia (without a FAB classification) NOS
    • Refractory anemia with excess blasts in transformation [RAEB T]
    Type 1 Excludes
    • acute exacerbation of chronic myeloid leukemia (C92.10)
    • refractory anemia with excess of blasts not in transformation (D46.2-)
  • C92.2: C92.1
    , D47.1
    2019 ICD-10-CM Diagnosis Code C92.1

    Chronic myeloid leukemia, BCR/ABL-positive

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Applicable To
    • Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
    • Chronic myelogenous leukemia, t(9;22) (q34;q11)
    • Chronic myelogenous leukemia with crisis of blast cells
    Type 1 Excludes
    • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
    • chronic myelomonocytic leukemia (C93.1-)
    • chronic myeloproliferative disease (D47.1)
    2019 ICD-10-CM Diagnosis Code D47.1

    Chronic myeloproliferative disease

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Chronic neutrophilic leukemia
    • Myeloproliferative disease, unspecified
    Type 1 Excludes
    • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
    • chronic myeloid leukemia BCR/ABL-positive (C92.1-)
    • myelofibrosis NOS (D75.81)
    • myelophthisic anemia (D61.82)
    • myelophthisis (D61.82)
    • secondary myelofibrosis NOS (D75.81)
  • C93: D72.825
    2019 ICD-10-CM Diagnosis Code D72.825

    Bandemia

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Bandemia without diagnosis of specific infection
    Type 1 Excludes
  • C93.1: C92.1
    , D46.Z
    2019 ICD-10-CM Diagnosis Code D46.Z

    Other myelodysplastic syndromes

      2016 2017 2018 2019 Billable/Specific Code
    Type 1 Excludes
    • chronic myelomonocytic leukemia (C93.1-)
    2019 ICD-10-CM Diagnosis Code C92.1

    Chronic myeloid leukemia, BCR/ABL-positive

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Applicable To
    • Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
    • Chronic myelogenous leukemia, t(9;22) (q34;q11)
    • Chronic myelogenous leukemia with crisis of blast cells
    Type 1 Excludes
    • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
    • chronic myelomonocytic leukemia (C93.1-)
    • chronic myeloproliferative disease (D47.1)
  • C94: D72.825
    2019 ICD-10-CM Diagnosis Code D72.825

    Bandemia

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Bandemia without diagnosis of specific infection
    Type 1 Excludes
  • C94.0: D53.1
    , D64.4
    2019 ICD-10-CM Diagnosis Code D53.1

    Other megaloblastic anemias, not elsewhere classified

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Megaloblastic anemia NOS
    Type 1 Excludes
    • Di Guglielmo's disease (C94.0)
    2019 ICD-10-CM Diagnosis Code D64.4

    Congenital dyserythropoietic anemia

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Dyshematopoietic anemia (congenital)
    Type 1 Excludes
    • Blackfan-Diamond syndrome (D61.01)
    • Di Guglielmo's disease (C94.0)
  • C94.3: D47.02
    , D89.4
    2019 ICD-10-CM Diagnosis Code D47.02

    Systemic mastocytosis

      2018 - New Code 2019 Billable/Specific Code
    Applicable To
    • Indolent systemic mastocytosis
    • Isolated bone marrow mastocytosis
    • Smoldering systemic mastocytosis
    • Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
    Code Also
    • , if applicable, any associated hematological non-mast cell lineage disease, such as:
    • acute myeloid leukemia (C92.6-, C92.A-)
    • chronic myelomonocytic leukemia (C93.1-)
    • essential thrombocytosis (D47.3)
    • hypereosinophilic syndrome (D72.1)
    • myelodysplastic syndrome (D46.9)
    • myeloproliferative syndrome (D47.1)
    • non-Hodgkin lymphoma (C82-C85)
    • plasma cell myeloma (C90.0-)
    • polycythemia vera (D45)
    Type 1 Excludes
    • aggressive systemic mastocytosis (C96.21)
    • mast cell leukemia (C94.3-)
    2019 ICD-10-CM Diagnosis Code D89.4

    Mast cell activation syndrome and related disorders

      2017 - New Code 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • aggressive systemic mastocytosis (C96.21)
    • congenital cutaneous mastocytosis (Q82.2)
    • (non-congenital) cutaneous mastocytosis (D47.01)
    • (indolent) systemic mastocytosis (D47.02)
    • malignant mast cell neoplasm (C96.2-)
    • malignant mastocytoma (C96.29)
    • mast cell leukemia (C94.3-)
    • mast cell sarcoma (C96.22)
    • mastocytoma NOS (D47.09)
    • other mast cell neoplasms of uncertain behavior (D47.09)
    • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
  • C94.30: C96.2
    2019 ICD-10-CM Diagnosis Code C96.2

    Malignant mast cell neoplasm

      2016 2017 2018 - Deleted Code 2018 - New Code 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • indolent mastocytosis (D47.02)
    • mast cell leukemia (C94.30)
    • mastocytosis (congenital) (cutaneous) (Q82.2)
  • C94.4: D47.4
    , D75.81
    2019 ICD-10-CM Diagnosis Code D47.4

    Osteomyelofibrosis

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Chronic idiopathic myelofibrosis
    • Myelofibrosis (idiopathic) (with myeloid metaplasia)
    • Myelosclerosis (megakaryocytic) with myeloid metaplasia
    • Secondary myelofibrosis in myeloproliferative disease
    Type 1 Excludes
    2019 ICD-10-CM Diagnosis Code D75.81

    Myelofibrosis

      2016 2017 2018 2019 Billable/Specific Code Manifestation Code
    Applicable To
    • Myelofibrosis NOS
    • Secondary myelofibrosis NOS
    Code First
    • the underlying disorder, such as:
    • malignant neoplasm of breast (C50.-)
    Type 1 Excludes
    • acute myelofibrosis (C94.4-)
    • idiopathic myelofibrosis (D47.1)
    • leukoerythroblastic anemia (D61.82)
    • myelofibrosis with myeloid metaplasia (D47.4)
    • myelophthisic anemia (D61.82)
    • myelophthisis (D61.82)
    • primary myelofibrosis (D47.1)
    Use Additional
    • code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
  • C95: D72.825
    2019 ICD-10-CM Diagnosis Code D72.825

    Bandemia

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Bandemia without diagnosis of specific infection
    Type 1 Excludes
  • C95.10: C95.0
    2019 ICD-10-CM Diagnosis Code C95.0

    Acute leukemia of unspecified cell type

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Applicable To
    • Acute bilineal leukemia
    • Acute mixed lineage leukemia
    • Biphenotypic acute leukemia
    • Stem cell leukemia of unclear lineage
    Type 1 Excludes
    • acute exacerbation of unspecified chronic leukemia (C95.10)
  • C95.9: Z85.6
    2019 ICD-10-CM Diagnosis Code Z85.6

    Personal history of leukemia

      2016 2017 2018 2019 Billable/Specific Code POA Exempt
    Applicable To
    • Conditions classifiable to C91-C95
    Type 1 Excludes
  • C96: C77
    2019 ICD-10-CM Diagnosis Code C77

    Secondary and unspecified malignant neoplasm of lymph nodes

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
    • mesentary metastasis of carcinoid tumor (C7B.04)
    • secondary carcinoid tumors of distant lymph nodes (C7B.01)
  • C96.0: C96.5
    , C96.6
    , D76
    , D76
    2019 ICD-10-CM Diagnosis Code C96.5

    Multifocal and unisystemic Langerhans-cell histiocytosis

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Hand-Schüller-Christian disease
    • Histiocytosis X, multifocal
    Type 1 Excludes
    • multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis (C96.0)
    • unifocal Langerhans-cell histiocytosis (C96.6)
    2019 ICD-10-CM Diagnosis Code C96.6

    Unifocal Langerhans-cell histiocytosis

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Eosinophilic granuloma
    • Histiocytosis X, unifocal
    • Histiocytosis X NOS
    • Langerhans-cell histiocytosis NOS
    Type 1 Excludes
    • multifocal and multisysemic (disseminated) Langerhans-cell histiocytosis (C96.0)
    • multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
  • C96.2: D47.0
    , D89.4
    , Q82.2
    2019 ICD-10-CM Diagnosis Code D89.4

    Mast cell activation syndrome and related disorders

      2017 - New Code 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • aggressive systemic mastocytosis (C96.21)
    • congenital cutaneous mastocytosis (Q82.2)
    • (non-congenital) cutaneous mastocytosis (D47.01)
    • (indolent) systemic mastocytosis (D47.02)
    • malignant mast cell neoplasm (C96.2-)
    • malignant mastocytoma (C96.29)
    • mast cell leukemia (C94.3-)
    • mast cell sarcoma (C96.22)
    • mastocytoma NOS (D47.09)
    • other mast cell neoplasms of uncertain behavior (D47.09)
    • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
    2019 ICD-10-CM Diagnosis Code Q82.2

    Congenital cutaneous mastocytosis

      2016 2017 2018 - Revised Code 2019 Billable/Specific Code POA Exempt
    Applicable To
    • Congenital diffuse cutaneous mastocytosis
    • Congenital maculopapular cutaneous mastocytosis
    • Congenital urticaria pigmentosa
    Type 1 Excludes
    • cutaneous mastocytosis NOS (D47.01)
    • diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
    • malignant mastocytosis (C96.2-)
    • systemic mastocytosis (D47.02)
    • urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)
    2019 ICD-10-CM Diagnosis Code D47.0

    Mast cell neoplasms of uncertain behavior

      2016 2017 2018 - Deleted Code 2018 - New Code 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • congenital cutaneous mastocytosis (Q82.2)
    • histiocytic neoplasms of uncertain behavior (D47.Z9)
    • malignant mast cell neoplasm (C96.2-)
  • C96.21: D47.02
    , D89.4
    2019 ICD-10-CM Diagnosis Code D47.02

    Systemic mastocytosis

      2018 - New Code 2019 Billable/Specific Code
    Applicable To
    • Indolent systemic mastocytosis
    • Isolated bone marrow mastocytosis
    • Smoldering systemic mastocytosis
    • Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
    Code Also
    • , if applicable, any associated hematological non-mast cell lineage disease, such as:
    • acute myeloid leukemia (C92.6-, C92.A-)
    • chronic myelomonocytic leukemia (C93.1-)
    • essential thrombocytosis (D47.3)
    • hypereosinophilic syndrome (D72.1)
    • myelodysplastic syndrome (D46.9)
    • myeloproliferative syndrome (D47.1)
    • non-Hodgkin lymphoma (C82-C85)
    • plasma cell myeloma (C90.0-)
    • polycythemia vera (D45)
    Type 1 Excludes
    • aggressive systemic mastocytosis (C96.21)
    • mast cell leukemia (C94.3-)
    2019 ICD-10-CM Diagnosis Code D89.4

    Mast cell activation syndrome and related disorders

      2017 - New Code 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • aggressive systemic mastocytosis (C96.21)
    • congenital cutaneous mastocytosis (Q82.2)
    • (non-congenital) cutaneous mastocytosis (D47.01)
    • (indolent) systemic mastocytosis (D47.02)
    • malignant mast cell neoplasm (C96.2-)
    • malignant mastocytoma (C96.29)
    • mast cell leukemia (C94.3-)
    • mast cell sarcoma (C96.22)
    • mastocytoma NOS (D47.09)
    • other mast cell neoplasms of uncertain behavior (D47.09)
    • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
  • C96.22: D89.4
    2019 ICD-10-CM Diagnosis Code D89.4

    Mast cell activation syndrome and related disorders

      2017 - New Code 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • aggressive systemic mastocytosis (C96.21)
    • congenital cutaneous mastocytosis (Q82.2)
    • (non-congenital) cutaneous mastocytosis (D47.01)
    • (indolent) systemic mastocytosis (D47.02)
    • malignant mast cell neoplasm (C96.2-)
    • malignant mastocytoma (C96.29)
    • mast cell leukemia (C94.3-)
    • mast cell sarcoma (C96.22)
    • mastocytoma NOS (D47.09)
    • other mast cell neoplasms of uncertain behavior (D47.09)
    • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
  • C96.29: D89.4
    2019 ICD-10-CM Diagnosis Code D89.4

    Mast cell activation syndrome and related disorders

      2017 - New Code 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • aggressive systemic mastocytosis (C96.21)
    • congenital cutaneous mastocytosis (Q82.2)
    • (non-congenital) cutaneous mastocytosis (D47.01)
    • (indolent) systemic mastocytosis (D47.02)
    • malignant mast cell neoplasm (C96.2-)
    • malignant mastocytoma (C96.29)
    • mast cell leukemia (C94.3-)
    • mast cell sarcoma (C96.22)
    • mastocytoma NOS (D47.09)
    • other mast cell neoplasms of uncertain behavior (D47.09)
    • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
  • C96.5: C96.0
    , C96.6
    , D76
    , D76
    , D76
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code C96.6

    Unifocal Langerhans-cell histiocytosis

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Eosinophilic granuloma
    • Histiocytosis X, unifocal
    • Histiocytosis X NOS
    • Langerhans-cell histiocytosis NOS
    Type 1 Excludes
    • multifocal and multisysemic (disseminated) Langerhans-cell histiocytosis (C96.0)
    • multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
    2019 ICD-10-CM Diagnosis Code C96.0

    Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Histiocytosis X, multisystemic
    • Letterer-Siwe disease
    Type 1 Excludes
    • adult pulmonary Langerhans cell histiocytosis (J84.82)
    • multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
    • unifocal Langerhans-cell histiocytosis (C96.6)
  • C96.6: C96.0
    , C96.5
    , D76
    , D76
    , D76
    , D76
    , E88
    2019 ICD-10-CM Diagnosis Code C96.0

    Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Histiocytosis X, multisystemic
    • Letterer-Siwe disease
    Type 1 Excludes
    • adult pulmonary Langerhans cell histiocytosis (J84.82)
    • multifocal and unisystemic Langerhans-cell histiocytosis (C96.5)
    • unifocal Langerhans-cell histiocytosis (C96.6)
    2019 ICD-10-CM Diagnosis Code C96.5

    Multifocal and unisystemic Langerhans-cell histiocytosis

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Hand-Schüller-Christian disease
    • Histiocytosis X, multifocal
    Type 1 Excludes
    • multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis (C96.0)
    • unifocal Langerhans-cell histiocytosis (C96.6)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code E88

    Other and unspecified metabolic disorders

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • histiocytosis X (chronic) (C96.6)
    Use Additional
    • codes for associated conditions
  • C96.9: D76
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
  • C96.A: D76
    , D76
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
    2019 ICD-10-CM Diagnosis Code D76

    Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • (Abt-) Letterer-Siwe disease (C96.0)
    • eosinophilic granuloma (C96.6)
    • Hand-Schüller-Christian disease (C96.5)
    • histiocytic medullary reticulosis (C96.9)
    • histiocytic sarcoma (C96.A)
    • histiocytosis X, multifocal (C96.5)
    • histiocytosis X, unifocal (C96.6)
    • Langerhans-cell histiocytosis, multifocal (C96.5)
    • Langerhans-cell histiocytosis NOS (C96.6)
    • Langerhans-cell histiocytosis, unifocal (C96.6)
    • leukemic reticuloendotheliosis (C91.4-)
    • lipomelanotic reticulosis (I89.8)
    • malignant histiocytosis (C96.A)
    • malignant reticulosis (C86.0)
    • nonlipid reticuloendotheliosis (C96.0)
  • D00.0: K13.2
    2019 ICD-10-CM Diagnosis Code K13.2

    Leukoplakia and other disturbances of oral epithelium, including tongue

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of oral epithelium (D00.0-)
    • hairy leukoplakia (K13.3)
  • D00.01: D04.0
    2019 ICD-10-CM Diagnosis Code D04.0

    Carcinoma in situ of skin of lip

      2016 2017 2018 2019 Billable/Specific Code
    Type 1 Excludes
    • carcinoma in situ of vermilion border of lip (D00.01)
  • D00.08: D02.0
    , D02.0
    , D02.0
    2019 ICD-10-CM Diagnosis Code D02.0

    Carcinoma in situ of larynx

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
    • Carcinoma in situ of epiglottis (suprahyoid portion)
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
    • carcinoma in situ of hypopharyngeal aspect (D00.08)
    • carcinoma in situ of marginal zone (D00.08)
    2019 ICD-10-CM Diagnosis Code D02.0

    Carcinoma in situ of larynx

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
    • Carcinoma in situ of epiglottis (suprahyoid portion)
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
    • carcinoma in situ of hypopharyngeal aspect (D00.08)
    • carcinoma in situ of marginal zone (D00.08)
    2019 ICD-10-CM Diagnosis Code D02.0

    Carcinoma in situ of larynx

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
    • Carcinoma in situ of epiglottis (suprahyoid portion)
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
    • carcinoma in situ of hypopharyngeal aspect (D00.08)
    • carcinoma in situ of marginal zone (D00.08)
  • D01.1: D01.0
    2019 ICD-10-CM Diagnosis Code D01.0

    Carcinoma in situ of colon

      2016 2017 2018 2019 Billable/Specific Code
    Type 1 Excludes
    • carcinoma in situ of rectosigmoid junction (D01.1)
  • D01.3: D04.5
    , K62.82
    , K62.82
    , K62.82
    , R85.61
    , R85.61
    , R85.61
    2019 ICD-10-CM Diagnosis Code D04.5

    Carcinoma in situ of skin of trunk

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of anal margin
    • Carcinoma in situ of anal skin
    • Carcinoma in situ of perianal skin
    • Carcinoma in situ of skin of breast
    Type 1 Excludes
    • carcinoma in situ of anus NOS (D01.3)
    • carcinoma in situ of scrotum (D07.61)
    • carcinoma in situ of skin of genital organs (D07.-)
    2019 ICD-10-CM Diagnosis Code K62.82

    Dysplasia of anus

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Anal intraepithelial neoplasia I and II (AIN I and II) (histologically confirmed)
    • Dysplasia of anus NOS
    • Mild and moderate dysplasia of anus (histologically confirmed)
    Type 1 Excludes
    • abnormal results from anal cytologic examination without histologic confirmation (R85.61-)
    • anal intraepithelial neoplasia III (D01.3)
    • carcinoma in situ of anus (D01.3)
    • HGSIL of anus (R85.613)
    • severe dysplasia of anus (D01.3)
    2019 ICD-10-CM Diagnosis Code K62.82

    Dysplasia of anus

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Anal intraepithelial neoplasia I and II (AIN I and II) (histologically confirmed)
    • Dysplasia of anus NOS
    • Mild and moderate dysplasia of anus (histologically confirmed)
    Type 1 Excludes
    • abnormal results from anal cytologic examination without histologic confirmation (R85.61-)
    • anal intraepithelial neoplasia III (D01.3)
    • carcinoma in situ of anus (D01.3)
    • HGSIL of anus (R85.613)
    • severe dysplasia of anus (D01.3)
    2019 ICD-10-CM Diagnosis Code K62.82

    Dysplasia of anus

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Anal intraepithelial neoplasia I and II (AIN I and II) (histologically confirmed)
    • Dysplasia of anus NOS
    • Mild and moderate dysplasia of anus (histologically confirmed)
    Type 1 Excludes
    • abnormal results from anal cytologic examination without histologic confirmation (R85.61-)
    • anal intraepithelial neoplasia III (D01.3)
    • carcinoma in situ of anus (D01.3)
    • HGSIL of anus (R85.613)
    • severe dysplasia of anus (D01.3)
    2019 ICD-10-CM Diagnosis Code R85.61

    Abnormal cytologic smear of anus

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other digestive organs and abdominal cavity (R85.69)
    • carcinoma in situ of anus (histologically confirmed) (D01.3)
    • anal intraepithelial neoplasia I [AIN I] (K62.82)
    • anal intraepithelial neoplasia II [AIN II] (K62.82)
    • anal intraepithelial neoplasia III [AIN III] (D01.3)
    • dysplasia (mild) (moderate) of anus (histologically confirmed) (K62.82)
    • severe dysplasia of anus (histologically confirmed) (D01.3)
    Type 2 Excludes
    • anal high risk human papillomavirus (HPV) DNA test positive (R85.81)
    • anal low risk human papillomavirus (HPV) DNA test positive (R85.82)
    2019 ICD-10-CM Diagnosis Code R85.61

    Abnormal cytologic smear of anus

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other digestive organs and abdominal cavity (R85.69)
    • carcinoma in situ of anus (histologically confirmed) (D01.3)
    • anal intraepithelial neoplasia I [AIN I] (K62.82)
    • anal intraepithelial neoplasia II [AIN II] (K62.82)
    • anal intraepithelial neoplasia III [AIN III] (D01.3)
    • dysplasia (mild) (moderate) of anus (histologically confirmed) (K62.82)
    • severe dysplasia of anus (histologically confirmed) (D01.3)
    Type 2 Excludes
    • anal high risk human papillomavirus (HPV) DNA test positive (R85.81)
    • anal low risk human papillomavirus (HPV) DNA test positive (R85.82)
    2019 ICD-10-CM Diagnosis Code R85.61

    Abnormal cytologic smear of anus

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other digestive organs and abdominal cavity (R85.69)
    • carcinoma in situ of anus (histologically confirmed) (D01.3)
    • anal intraepithelial neoplasia I [AIN I] (K62.82)
    • anal intraepithelial neoplasia II [AIN II] (K62.82)
    • anal intraepithelial neoplasia III [AIN III] (D01.3)
    • dysplasia (mild) (moderate) of anus (histologically confirmed) (K62.82)
    • severe dysplasia of anus (histologically confirmed) (D01.3)
    Type 2 Excludes
    • anal high risk human papillomavirus (HPV) DNA test positive (R85.81)
    • anal low risk human papillomavirus (HPV) DNA test positive (R85.82)
  • D01.5: D01.4
    2019 ICD-10-CM Diagnosis Code D01.4

    Carcinoma in situ of other and unspecified parts of intestine

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of ampulla of Vater (D01.5)
  • D01.7: D09.3
    2019 ICD-10-CM Diagnosis Code D09.3

    Carcinoma in situ of thyroid and other endocrine glands

      2016 2017 2018 2019 Billable/Specific Code
    Type 1 Excludes
    • carcinoma in situ of endocrine pancreas (D01.7)
    • carcinoma in situ of ovary (D07.39)
    • carcinoma in situ of testis (D07.69)
  • D02.0: D00.0
    , D00.0
    , D00.0
    2019 ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
    2019 ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
    2019 ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
  • D03: C43
    , D00
    , D01
    , D02
    , D04
    , D09
    2019 ICD-10-CM Diagnosis Code D01

    Carcinoma in situ of other and unspecified digestive organs

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    2019 ICD-10-CM Diagnosis Code D02

    Carcinoma in situ of middle ear and respiratory system

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
    2019 ICD-10-CM Diagnosis Code D09

    Carcinoma in situ of other and unspecified sites

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    2019 ICD-10-CM Diagnosis Code D04

    Carcinoma in situ of skin

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • erythroplasia of Queyrat (penis) NOS (D07.4)
    • melanoma in situ (D03.-)
    2019 ICD-10-CM Diagnosis Code D00

    Carcinoma in situ of oral cavity, esophagus and stomach

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    2019 ICD-10-CM Diagnosis Code C43

    Malignant melanoma of skin

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    Type 2 Excludes
    • malignant melanoma of skin of genital organs (C51-C52, C60.-, C63.-)
    • Merkel cell carcinoma (C4A.-)
    • sites other than skin-code to malignant neoplasm of the site
  • D03.0: D00.0
    2019 ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
  • D03.5: D05
    , D06
    , D07
    2019 ICD-10-CM Diagnosis Code D05

    Carcinoma in situ of breast

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of skin of breast (D04.5)
    • melanoma in situ of breast (skin) (D03.5)
    • Paget's disease of breast or nipple (C50.-)
    2019 ICD-10-CM Diagnosis Code D06

    Carcinoma in situ of cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Includes
    • cervical adenocarcinoma in situ
    • cervical intraepithelial glandular neoplasia
    • cervical intraepithelial neoplasia III [CIN III]
    • severe dysplasia of cervix uteri
    Type 1 Excludes
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cytologic evidence of malignancy of cervix without histologic confirmation (R87.614)
    • high grade squamous intraepithelial lesion (HGSIL) of cervix (R87.613)
    • melanoma in situ of cervix (D03.5)
    • moderate cervical dysplasia (N87.1)
    2019 ICD-10-CM Diagnosis Code D07

    Carcinoma in situ of other and unspecified genital organs

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • melanoma in situ of trunk (D03.5)
  • D04.0: D00.0
    2019 ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
  • D04.1: D09.2
    2019 ICD-10-CM Diagnosis Code D09.2

    Carcinoma in situ of eye

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of skin of eyelid (D04.1-)
  • D04.2: D02.3
    2019 ICD-10-CM Diagnosis Code D02.3

    Carcinoma in situ of other parts of respiratory system

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of accessory sinuses
    • Carcinoma in situ of middle ear
    • Carcinoma in situ of nasal cavities
    Type 1 Excludes
    • carcinoma in situ of ear (external) (skin) (D04.2-)
    • carcinoma in situ of nose NOS D09.8
    • carcinoma in situ of skin of nose (D04.3)
  • D04.3: D02.3
    2019 ICD-10-CM Diagnosis Code D02.3

    Carcinoma in situ of other parts of respiratory system

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of accessory sinuses
    • Carcinoma in situ of middle ear
    • Carcinoma in situ of nasal cavities
    Type 1 Excludes
    • carcinoma in situ of ear (external) (skin) (D04.2-)
    • carcinoma in situ of nose NOS D09.8
    • carcinoma in situ of skin of nose (D04.3)
  • D04.5: D01.3
    , D01.3
    , D01.3
    , D05
    2019 ICD-10-CM Diagnosis Code D01.3

    Carcinoma in situ of anus and anal canal

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Anal intraepithelial neoplasia III [AIN III]
    • Severe dysplasia of anus
    Type 1 Excludes
    • anal intraepithelial neoplasia I and II [AIN I and AIN II] (K62.82)
    • carcinoma in situ of anal margin (D04.5)
    • carcinoma in situ of anal skin (D04.5)
    • carcinoma in situ of perianal skin (D04.5)
    2019 ICD-10-CM Diagnosis Code D01.3

    Carcinoma in situ of anus and anal canal

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Anal intraepithelial neoplasia III [AIN III]
    • Severe dysplasia of anus
    Type 1 Excludes
    • anal intraepithelial neoplasia I and II [AIN I and AIN II] (K62.82)
    • carcinoma in situ of anal margin (D04.5)
    • carcinoma in situ of anal skin (D04.5)
    • carcinoma in situ of perianal skin (D04.5)
    2019 ICD-10-CM Diagnosis Code D01.3

    Carcinoma in situ of anus and anal canal

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Anal intraepithelial neoplasia III [AIN III]
    • Severe dysplasia of anus
    Type 1 Excludes
    • anal intraepithelial neoplasia I and II [AIN I and AIN II] (K62.82)
    • carcinoma in situ of anal margin (D04.5)
    • carcinoma in situ of anal skin (D04.5)
    • carcinoma in situ of perianal skin (D04.5)
    2019 ICD-10-CM Diagnosis Code D05

    Carcinoma in situ of breast

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of skin of breast (D04.5)
    • melanoma in situ of breast (skin) (D03.5)
    • Paget's disease of breast or nipple (C50.-)
  • D06: C53
    , N87
    , N87
    , N87
    , R87.61
    , R87.61
    , R87.61
    , R87.7
    , R87.7
    2019 ICD-10-CM Diagnosis Code C53

    Malignant neoplasm of cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of cervix uteri (D06.-)
    2019 ICD-10-CM Diagnosis Code N87

    Dysplasia of cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
    • carcinoma in situ of cervix uteri (D06.-)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • HGSIL of cervix (R87.613)
    • severe dysplasia of cervix uteri (D06.-)
    2019 ICD-10-CM Diagnosis Code N87

    Dysplasia of cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
    • carcinoma in situ of cervix uteri (D06.-)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • HGSIL of cervix (R87.613)
    • severe dysplasia of cervix uteri (D06.-)
    2019 ICD-10-CM Diagnosis Code N87

    Dysplasia of cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
    • carcinoma in situ of cervix uteri (D06.-)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • HGSIL of cervix (R87.613)
    • severe dysplasia of cervix uteri (D06.-)
    2019 ICD-10-CM Diagnosis Code R87.61

    Abnormal cytological findings in specimens from cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • abnormal cytological findings in specimens from vagina (R87.62-)
    • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    Type 2 Excludes
    • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
    • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
    2019 ICD-10-CM Diagnosis Code R87.61

    Abnormal cytological findings in specimens from cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • abnormal cytological findings in specimens from vagina (R87.62-)
    • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    Type 2 Excludes
    • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
    • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
    2019 ICD-10-CM Diagnosis Code R87.61

    Abnormal cytological findings in specimens from cervix uteri

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • abnormal cytological findings in specimens from vagina (R87.62-)
    • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    Type 2 Excludes
    • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
    • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
    2019 ICD-10-CM Diagnosis Code R87.7

    Abnormal histological findings in specimens from female genital organs

      2016 2017 2018 2019 Billable/Specific Code Female Dx
    Type 1 Excludes
    • carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    2019 ICD-10-CM Diagnosis Code R87.7

    Abnormal histological findings in specimens from female genital organs

      2016 2017 2018 2019 Billable/Specific Code Female Dx
    Type 1 Excludes
    • carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
  • D07: D04.5
    2019 ICD-10-CM Diagnosis Code D04.5

    Carcinoma in situ of skin of trunk

      2016 2017 2018 2019 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of anal margin
    • Carcinoma in situ of anal skin
    • Carcinoma in situ of perianal skin
    • Carcinoma in situ of skin of breast
    Type 1 Excludes
    • carcinoma in situ of anus NOS (D01.3)
    • carcinoma in situ of scrotum (D07.61)
    • carcinoma in situ of skin of genital organs (D07.-)
  • D07.1: C51
    , N90
    , N90
    , N90
    2019 ICD-10-CM Diagnosis Code C51

    Malignant neoplasm of vulva

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of vulva (D07.1)
    2019 ICD-10-CM Diagnosis Code N90

    Other noninflammatory disorders of vulva and perineum

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • anogenital (venereal) warts (A63.0)
    • carcinoma in situ of vulva (D07.1)
    • condyloma acuminatum (A63.0)
    • current obstetric trauma (O70.-, O71.7-O71.8)
    • inflammation of vulva (N76.-)
    • severe dysplasia of vulva (D07.1)
    • vulvar intraepithelial neoplasm III [VIN III] (D07.1)
    2019 ICD-10-CM Diagnosis Code N90

    Other noninflammatory disorders of vulva and perineum

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • anogenital (venereal) warts (A63.0)
    • carcinoma in situ of vulva (D07.1)
    • condyloma acuminatum (A63.0)
    • current obstetric trauma (O70.-, O71.7-O71.8)
    • inflammation of vulva (N76.-)
    • severe dysplasia of vulva (D07.1)
    • vulvar intraepithelial neoplasm III [VIN III] (D07.1)
    2019 ICD-10-CM Diagnosis Code N90

    Other noninflammatory disorders of vulva and perineum

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • anogenital (venereal) warts (A63.0)
    • carcinoma in situ of vulva (D07.1)
    • condyloma acuminatum (A63.0)
    • current obstetric trauma (O70.-, O71.7-O71.8)
    • inflammation of vulva (N76.-)
    • severe dysplasia of vulva (D07.1)
    • vulvar intraepithelial neoplasm III [VIN III] (D07.1)
  • D07.2: C52
    , N89
    , N89
    , N89
    , R87.7
    2019 ICD-10-CM Diagnosis Code N89

    Other noninflammatory disorders of vagina

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
    • carcinoma in situ of vagina (D07.2)
    • HGSIL of vagina (R87.623)
    • inflammation of vagina (N76.-)
    • senile (atrophic) vaginitis (N95.2)
    • severe dysplasia of vagina (D07.2)
    • trichomonal leukorrhea (A59.00)
    • vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
    2019 ICD-10-CM Diagnosis Code N89

    Other noninflammatory disorders of vagina

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
    • carcinoma in situ of vagina (D07.2)
    • HGSIL of vagina (R87.623)
    • inflammation of vagina (N76.-)
    • senile (atrophic) vaginitis (N95.2)
    • severe dysplasia of vagina (D07.2)
    • trichomonal leukorrhea (A59.00)
    • vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
    2019 ICD-10-CM Diagnosis Code C52

    Malignant neoplasm of vagina

      2016 2017 2018 2019 Billable/Specific Code Female Dx
    Type 1 Excludes
    • carcinoma in situ of vagina (D07.2)
    2019 ICD-10-CM Diagnosis Code N89

    Other noninflammatory disorders of vagina

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
    • carcinoma in situ of vagina (D07.2)
    • HGSIL of vagina (R87.623)
    • inflammation of vagina (N76.-)
    • senile (atrophic) vaginitis (N95.2)
    • severe dysplasia of vagina (D07.2)
    • trichomonal leukorrhea (A59.00)
    • vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
    2019 ICD-10-CM Diagnosis Code R87.7

    Abnormal histological findings in specimens from female genital organs

      2016 2017 2018 2019 Billable/Specific Code Female Dx
    Type 1 Excludes
    • carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)